AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
41,000
-9,200 (-18.33%)
At close: Jun 8, 2026
Market Cap970.50B +169.8%
Revenue (ttm)725.35M -97.6%
Net Income-10.12B
EPS-449.15
Shares Out 23.41M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume661,735
Open44,400
Previous Close50,200
Day's Range39,500 - 44,950
52-Week Range16,160 - 76,700
Beta1.45
Analystsn/a
Price Targetn/a
Earnings Daten/a

About AprilBio

AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements